167 related articles for article (PubMed ID: 38115142)
1. Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999-2019.
Montravers P; Grall N; Kantor E; Augustin P; Boussion K; Zappella N
World J Emerg Surg; 2023 Dec; 18(1):58. PubMed ID: 38115142
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.
Augustin P; Kermarrec N; Muller-Serieys C; Lasocki S; Chosidow D; Marmuse JP; Valin N; Desmonts JM; Montravers P
Crit Care; 2010; 14(1):R20. PubMed ID: 20156360
[TBL] [Abstract][Full Text] [Related]
3. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
Cleland H; Tracy LM; Padiglione A; Stewardson AJ
Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
Jaccard C; Troillet N; Harbarth S; Zanetti G; Aymon D; Schneider R; Chiolero R; Ricou B; Romand J; Huber O; Ambrosetti P; Praz G; Lew D; Bille J; Glauser MP; Cometta A
Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
[TBL] [Abstract][Full Text] [Related]
5. [Bacteriological profile and antibiotic treatment of postoperative peritonitis].
Missaoui K; Marzougui Y; Kouka J; Dhibi Y; Hannachi Z; Dziri C; Houissa M
Arch Inst Pasteur Tunis; 2014; 91(1-4):57-66. PubMed ID: 26485771
[TBL] [Abstract][Full Text] [Related]
6. Retrospective data analysis for definition of multidrug resistance in gram-negative bacteria - a consensus proposal.
Friedli O; Völlmy I; Schrenzel J; Harbarth S; Kronenberg A;
Swiss Med Wkly; 2022 Jul; 152():w30195. PubMed ID: 35816628
[TBL] [Abstract][Full Text] [Related]
7. Empiric therapy for secondary peritonitis: a pharmacodynamic analysis of cefepime, ceftazidime, ceftriaxone, imipenem, levofloxacin, piperacillin/tazobactam, and tigecycline using Monte Carlo simulation.
Eagye KJ; Kuti JL; Dowzicky M; Nicolau DP
Clin Ther; 2007 May; 29(5):889-899. PubMed ID: 17697907
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Hundeshagen G; Herndon DN; Capek KD; Branski LK; Voigt CD; Killion EA; Cambiaso-Daniel J; Sljivich M; De Crescenzo A; Mlcak RP; Kinsky MP; Finnerty CC; Norbury WB
Crit Care; 2017 Dec; 21(1):318. PubMed ID: 29262848
[TBL] [Abstract][Full Text] [Related]
9. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
10. Identifying patients at high risk for multidrug-resistant organisms after hospitalization abroad.
Bopp TC; Marchesi M; Zihlmann R; Sax H; Wolfensberger A
Infect Control Hosp Epidemiol; 2023 Aug; 44(8):1281-1288. PubMed ID: 36912341
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure.
Guo S; Yang L; Zhu X; Zhang X; Meng L; Li X; Cheng S; Zhuang X; Liu S; Cui W
Front Med (Lausanne); 2023; 10():1132695. PubMed ID: 37234246
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.
Brink AJ; Botha RF; Poswa X; Senekal M; Badal RE; Grolman DC; Richards GA; Feldman C; Boffard KD; Veller M; Joubert I; Pretorius J
Surg Infect (Larchmt); 2012 Feb; 13(1):43-9. PubMed ID: 22220506
[TBL] [Abstract][Full Text] [Related]
13. European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.
Kajova M; Khawaja T; Kantele A
J Travel Med; 2022 Jul; 29(4):. PubMed ID: 35234907
[TBL] [Abstract][Full Text] [Related]
14. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
[TBL] [Abstract][Full Text] [Related]
15. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
Magira EE; Islam S; Niederman MS
Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
[TBL] [Abstract][Full Text] [Related]
16. Emergence of multi-drug resistant organisms (MDROs) causing Fournier's gangrene.
Chia L; Crum-Cianflone NF
J Infect; 2018 Jan; 76(1):38-43. PubMed ID: 28962969
[TBL] [Abstract][Full Text] [Related]
17. Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients.
Steinbach CL; Töpper C; Adam T; Kees MG
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():48. PubMed ID: 26541549
[TBL] [Abstract][Full Text] [Related]
18. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
19. Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study.
Augustin P; Tanaka S; Tran-Dinh A; Parenti Ribeiro L; Arapis K; Grall N; Al Qarni A; Montravers P
Surg Infect (Larchmt); 2020 Apr; 21(3):284-292. PubMed ID: 31770083
[No Abstract] [Full Text] [Related]
20. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
